NASDAQ:TNXP

Tonix Pharmaceuticals Stock News

etoro logo Buy TNXP
*Your capital is at risk
$12.20
+0.190 (+1.58%)
At Close: Jun 22, 2026
The company is stopping enrollment in a late-stage study for its lead pipeline candidate.
The stock price of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) fell by over 30% pre-market. This is why it happened.
Following an unblinded, pre-planned interim analysis by the Independent Data Monitoring Committee (IDMC), Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) will stop enrollment in the Phase 3 RALLY

TNXP Stock Fell 2.97%: Why It Happened

10:26pm, Friday, 23'rd Jul 2021
The stock price of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) fell 2.97% today. This is why it happened.
RALLY Study Will Stop Enrolling New Participants Following Recommendation from an Interim Analysis Indicating Inadequate Separation from Placebo at Week-14 in the First 50% of Participants, Based on t
Trending penny stocks can be a great addition to your watchlist, here's 7 popular small-caps for your list The post Popular Penny Stocks to Buy Right Now? 7 For Your Watchlist appeared first on Penny
Making a penny stocks watchlist for July? Check these 8 out The post Penny Stocks To Buy in 2021?
CHATHAM, N.J., June 28, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Tonix was a

TNXP Stock Price Increased 8.18%: Why It Happened

08:20am, Saturday, 26'th Jun 2021
The stock price of Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) increased 8.18% yesterday. This is why it happened.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) said in a regulatory filing that plans are underway to construct a commercial-scale manufacturing site to develop and manufacture vaccines, includi
Long COVID Symptoms of Pain, Sleep Disturbance, Fatigue and Brain Fog Overlap with Symptoms of Fibromyalgia, for which TNX-102 SL is in Mid-Phase 3 Development
CHATHAM, N.J., June 16, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederm
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced the poster presentation of previously reported results from its Phase 3 RELIEF trial evaluating the TNX-102 SL tablet for the manag
Lots of irons in the fire could be distracting investors from the most serious problem this company faces right now.
Announced Positive Efficacy Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE